Clinical Trial Update: A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MIN-102 for progression in Friedreich's Ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• MIN-102

Snippet

Sponsor: Minoryx Therapeutics, S.L. | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED